EUVIMEDEUVIMED entdecken
Crossref

ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma

Pedro Nicolau-Neto iD, Bernardo Cacciari Peryassú, Flávia Nascimento de Carvalho, Paulo Thiago Souza-Santos, Priscila Valverde, Cristina Moreira Nascimento, Izabella Costa, Fernando L Dias, Luis Felipe Ribeiro Pinto

Head & Neck · 2024

DOI: 10.1002/hed.27635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2024. Verfasst von Pedro Nicolau-Neto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Carcinogênese Molecular, Instituto Nacional de Câncer-INCA, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Carcinoma, Squamous Cell, Head and Neck Neoplasms. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Swiss Bridge Foundation, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Laryngeal squamous cell carcinoma (LSCC) is the second most frequent head and neck tumor. Prognosis of patients with LSCC has not improved in recent decades, showing a need for the identification of prognostic biomarkers and new therapeutic targets. Recently, we showed that ALCAM overexpression was associated with glottic LSCC prognosis. Objectives and methods Aiming to validate the prognostic value of ALCAM, we evaluate the ALCAM protein levels by immunohistochemistry in 263 glottic LSCC surgically treated with neck dissection.

Results

ALCAM was expressed in 48.7% and overexpressed in 36.5% of glottic LSCC samples. ALCAM overexpression was associated with lymph node metastasis ( p = 0.030), lymphovascular involvement ( p = 0.0002), high‐grade tumors ( p = 0.025), and tumor relapse ( p = 0.043). Multivariate survival analyses showed an overfitting between ALCAM overexpression and lymph node metastasis as a prognostic variable.

Conclusions

High ALCAM expression was associated with an aggressive glottic LSCC profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsCarcinoma, Squamous CellHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckActivated-Leukocyte Cell Adhesion MoleculeLymphatic MetastasisBiomarkers, TumorNeoplasm Recurrence, LocalPrognosis

Stichwörter der Autor:innen

ALCAM expressionlaryngeal squamous cell carcinomaprognostic biomarker

Substanzen

Activated-Leukocyte Cell Adhesion MoleculeBiomarkers, TumorALCAM protein, human

Autor:innen und Institutionen

  • Programa de Carcinogênese Molecular, Instituto Nacional de Câncer-INCA, Rio de Janeiro, Brazil.
  • Seção de Cirurgia de Cabeça e Pescoço, Instituto Nacional de Câncer-INCA, Rio de Janeiro, Brazil.
  • Biologia Molecular, Beneficência Portuguesa de São Paulo, São Paulo, Brazil.
  • Divisão de Patologia, Instituto Nacional de Câncer-INCA, Rio de Janeiro, Brazil.
  • Departamento de Bioquímica, Instituto de Biologia Roberto Alcântara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Pedro Nicolau-Neto

Förderung

  • Swiss Bridge Foundation
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Nicolau-Neto, P., Peryassú, B. C., de Carvalho, F. N., Souza-Santos, P. T., Valverde, P., Nascimento, C. M., Costa, I., Dias, F. L., & Pinto, L. F. R. (2024). ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma. Head & Neck. https://doi.org/10.1002/hed.27635

Vancouver

Nicolau-Neto P, Peryassú BC, de Carvalho FN, Souza-Santos PT, Valverde P, Nascimento CM, et al. ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma. Head & Neck. 2024. doi:10.1002/hed.27635

BibTeX
@article{NicolauNeto2024,
  author = {Nicolau-Neto, Pedro and Peryassú, Bernardo Cacciari and de Carvalho, Flávia Nascimento and Souza-Santos, Paulo Thiago and Valverde, Priscila and Nascimento, Cristina Moreira and Costa, Izabella and Dias, Fernando L and Pinto, Luis Felipe Ribeiro},
  title = {ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma},
  journal = {Head & Neck},
  year = {2024},
  doi = {10.1002/hed.27635}
}
Kostenlos starten →